[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"incurable-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:incurable-disease":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100526705","the-effect-of-exercise-and-diet-on-quality-of-life-in-patients-with-incurable-cancer-of-esophagus-and-stomach-radices-100526705",false,"NCT06138223","The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)","RADICES","Inclusion Criteria:\n\n* Incurable adenocarcinoma of the esophagus or stomach\n* Recurrence after treatment with curative intent or irresectable\u002Fmetastatic disease at primary diagnosis. Inclusion can take place regardless of the plan or the actual initiation of multi-line systemic treatment. (i.e. patients that have already started with anticancer therapy are eligible for inclusion too)\\*\n* Able and willing to perform the exercise and nutritional program and wear the activity tracker.\n* Able and willing to fill out the POCOP\u002FRADICES questionnaires.\n* Life expectancy \\> 12 weeks.\n* Age ≥ 18 years.\n\nExclusion Criteria:\n\n* Unstable bone metastases inducing skeletal fragility as determined by the treating clinician.\n* Untreated symptomatic known brain metastasis.\n* Serious active infection.\n* Too physically active (i.e. \\>210 minutes\u002Fweek of moderate-to-vigorous intentional exercise) or engaging in intense exercise training comparable to the RADICES exercise program.\n* Severe neurologic or cardiac impairment according to the American College of Sports Medicine criteria.\n* Uncontrolled severe respiratory insufficiency as determined by the treating clinician or if the patient is dependent on oxygen suppletion in rest or during exercise.\n* Uncontrolled severe pain.\n* Any other contraindications for exercise as determined by the treating physician.\n* Any circumstances that would impede adherence to study requirements or ability to give informed consent, as determined by the treating clinician.\n* Pregnancy.\n\n  * Note:\n\nAfter one year of recruitment we broadened our inclusion criteria from GAC patients receiving beyond first-line palliative treatment or best supportive care to any patient with recurrence\u002Fprogression of GAC after curative treatment or irresectable\u002Fmetastatic disease at diagnosis, regardless of timing or type of palliative treatment and number of lines received. This was done to increase generalizability and offer the intervention earlier in the palliative phase to enhance its benefits. We acknowledge this results in a more heterogeneous group, but we believe also a more representative group.\n\nThe inclusion criterium before broadening was:\n\nProgressive disease after first-line palliative systemic treatment OR within 6 months after completion of curative treatment (i.e. within six months after neoadjuvant chemoradiation, adjuvant nivolumab, or definitive chemoradiation for esophageal adenocarcinoma or within six months after adjuvant 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) for gastric\u002Fesophageal cancer or neoadjuvant FLOT if no adjuvant FLOT was given, or after progression during participation in the LyRICX study). Patients on capecitabine monotherapy who are eligible for oxaliplatin reintroduction can be included, too.","ALL","18 Years",{"count":19,"type":20},196,"ESTIMATED","INTERVENTIONAL",[23],"NA","The survival of patients with incurable gastroesophageal cancer can extend over a year with anticancer therapy. However, the number of patients with deteriorating quality of life in this patient group steadily decreases over time during the treatment. Potentially reversible causes related to deterioration of quality of life are diminished muscle mass, physical capacity and nutritional status. Therefore, interventions that can target these in order to maintain or improve quality of life are urgently needed.\n\nHowever, it is yet unknown whether improvement of physical capacity and nutritional status improves quality of life in patients with incurable gastroesophageal adenocarcinoma after failure of first-line treatment. Since these patients are in a precarious situation, the benefits and harms of a combined exercise and nutritional intervention should be carefully evaluated.Therefore this study investigates the effect of a combined exercise and nutrition intervention compared to usual care on quality of life in incurable GAC patients after progression upon first-line treatment.\n\nA total of 196 patients with metastasized gastroesophageal cancer will be recruited and randomly allocated 1:1 to standard care or standard care plus a combined exercise and nutritional intervention.",[26,27],"GastroEsophageal Cancer","Incurable Disease",[29,30,31,32,33,34,35],"gastroesophageal cancer","GAC","Palliative","exercise intervention","nutritional intervention","Quality of life","QOL","RECRUITING","2026-05-03",{"date":39,"type":40},"2026-05-07","ACTUAL",{"date":42,"type":40},"2024-01-01",{"date":44,"type":20},"2028-09-30",{"name":46,"class":47},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","OTHER",22,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":59,"conditions":60,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":70},"100388862","generating-novel-therapeutic-strategies-based-on-evolutionary-tumor-board-100388862","NCT04343365","Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board","Feasibility of Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board in Cancer Patients","Inclusion Criteria:\n\n* Participant must be considered likely incurable given a standard of care. This is inclusive of participants in remission but at high risk of recurrence, with suboptimal responses to previous therapy, or with many potentially beneficial, but not curative options for care.\n* Participant must have a life expectancy greater than 3 months\n* Participant must have an ECOG performance status 0-2\n* Participant and primary Oncologist are willing to consider the therapeutic strategies recommended by the ETB\n* Willingness to be followed over time and allowing collection of clinical data including scans and serial blood sampling.\n\nExclusion Criteria:\n\n* None",{"count":57,"type":20},35,"OBSERVATIONAL","This study will evaluate the ability of a multidisciplinary group, the Evolutionary Tumor Board (ETB), to develop therapeutic strategies in patients without curative options.",[27],"2026-03-31",{"date":63,"type":40},"2026-04-01",{"date":65,"type":40},"2020-05-05",{"date":67,"type":20},"2028-03",{"name":69,"class":47},"H. Lee Moffitt Cancer Center and Research Institute",1]